Insider Trading & Ownership - Lawson Byron

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Lawson Byron

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-12-09
Option Award
2022-12-13
5:41 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
1,000$0.4256,033
(Direct)
View
2022-08-18
Option Award
2022-08-22
5:51 pm
N/A
2032-08-17
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
20,000$020,000
(Direct)
View
2022-06-30
Tax Withholding
2022-07-01
5:42 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
23$1.035,033
(Direct)
View
2022-06-10
Option Award
2022-06-15
4:31 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
1,000$0.4765,056
(Direct)
View
2022-03-31
Tax Withholding
2022-04-04
4:30 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
23$1.394,056
(Direct)
View
2021-12-31
Tax Withholding
2022-01-04
4:40 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
24$5.424,079
(Direct)
View
2021-12-10
Option Award
2021-12-15
5:06 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
896$3.56154,103
(Direct)
View
2021-09-30
Tax Withholding
2021-10-04
4:36 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
24$5.713,207
(Direct)
View
2021-06-30
Tax Withholding
2021-07-02
7:18 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
24$5.813,231
(Direct)
View
2021-06-10
Option Award
2021-06-14
8:30 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
354$3.91853,255
(Direct)
View
2021-03-31
Tax Withholding
2021-04-02
5:49 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
28$5.472,901
(Direct)
View
2020-12-31
Tax Withholding
2021-01-04
5:57 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
24$4.792,929
(Direct)
View
2020-12-10
Option Award
2020-12-16
6:13 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
66$4.87052,953
(Direct)
View
2020-09-30
Tax Withholding
2020-10-02
5:47 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
350$0.3343,333
(Direct)
View
2020-08-20
Option Award
2020-08-24
6:01 pm
N/A
2030-08-19
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
270,000$0270,000
(Direct)
View
2020-06-30
Tax Withholding
2020-07-02
5:23 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
350$0.7243,683
(Direct)
View
2020-06-10
Option Award
2020-06-15
6:21 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
1,000$0.552544,033
(Direct)
View
2020-03-31
Tax Withholding
2020-04-02
4:14 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
416$0.3343,033
(Direct)
View

Ownership
2020-02-03
4:32 pm
N/A
N/A
HTG MOLECULAR DIAGNOSTICS INCHTGMLawson Byron
SVP/Chief Commercial Officer
0$0291,071
(Direct)
View